Insider filing · AXSM
Ari Maizel
Chief Commercial Officer
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Ari Maizel sold $1.4M of Axsome Therapeutics (AXSM)
Executed Apr 22, disclosed Apr 23, 1 day later.
Value, as filed
$1.4M
7,500 sh × $182.42
Executed
Apr 22
the trade date, as filed
Disclosed
Apr 23
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AMAri Maizel (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $1.4M of AXSM (7,500 sh × $184.44, as filed), executed Jan 21.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ari Maizel in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$1.4M7,500 sh × $184.44
Exec Jan 21
Filed Jan 23 · 5:30 PM ET